Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 6426075

Protease-activatable pseudomonas exotoxin A-like proproteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6420434

Active topical skin protectants using polyoxometallates

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6417236

Active topical skin protectants using hybrid organic polysilsesquioxane materials

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6414039

Active topical skin protectants containing polyoxometalates and/or coinage metal complexes

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410604

Active topical skin protectants containing OPAA enzymes and clecs

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410603

Active topical skin protectants using combinations of reactive nanoparticles and polyoxome

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410537

Compositions having neuroprotective and analgesic activity

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410056

Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410012

Antimicrobial mediated bacterial DNA delivery

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6406887

Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6403653

Active topical skin protectants using reactive nanoparticles

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 11 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6403635

Method of treating atherosclerosis or restenosis using microtubule stabilizing agent

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 11 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6399743

Isolation and characterization of a rat epidermal growth factor related protein

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6399332

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6391651

Materials and methods for detection of insulin dependent diabetes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6387399

Microencapsulated bioactive agents and method of making

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6387389

Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6379677

Streptococcus iniae vaccine

The United States of America as Represented by the Secretary of the Department of Agriculture · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6379660

Nitric oxide-releasing 1-[(2-carboxylato)pyrrolidin-1-yl] diazen-1-ium-1,2-diolates and co

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6368662

Molecular level coating of metal oxide particles

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6365712

Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammali

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6353019

Macrocyclic lactones, compositions, and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6339102

Method and composition for treating and preventing retinal damage

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 15 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6326466

Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)